32
Participants
Start Date
November 25, 2025
Primary Completion Date
November 1, 2027
Study Completion Date
December 31, 2027
Empagliflozin (Jardiance®)
Empagliflozin (Jardiance®), 10 mg tablet taken orally once daily for 4 weeks. Dispensed at baseline by the Investigational Drug Service. It will be administered at home by participants.
University of Chicago, Chicago
National Institutes of Health (NIH)
NIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Chicago
OTHER